• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Cardiology

Quantitative flow ratio-guided coronary intervention reduces the rate of major cardiac events compared to visual angiography

byJessie WillisandTeddy Guo
December 21, 2021
in Cardiology, Chronic Disease
Reading Time: 2 mins read
Drug-coated balloons are noninferior to drug-eluting stents for treatment of small vessel coronary artery disease
Share on FacebookShare on Twitter

1. Quantitative flow ratio (QFR) allowed for better periprocedural assessment of stenoses, leading to a lower amount of unnecessary stenting procedures.

2. After 1 year, those who had underwent QFR-guided PCI had less adverse outcomes compared to angiography-guided.

Evidence Rating Level: 1 (Excellent)

Study Rundown: During percutaneous coronary intervention (PCI), angiography remains the most common tool to visualize the arteries during the procedure. Another method is QFR-guided PCI, which estimates fractional flow reserve by using a pressure wire-based measurement to assess the extent of the stenosis in the coronary arteries. This study enrolled patients set to undergo a PCI procedure and all patients had a revascularization plan made by angiography. Patients were then randomized to undergo PCI guided by angiography or QFR. During the procedure, QFR allowed for a more accurate assessment of the stenoses visually identified for PCI. Notably, in around a fifth of patients in the PCI group, the original revascularization plan was changed because stenoses thought to be severe were found to be not hemodynamically obstructive by QFR. Overall, less stents were placed than originally planned in the QFR group, which correlated to fewer periprocedural myocardial infarctions. In some patients, this led to zero stents being placed. After the 1-year follow-up period, there were fewer events of the composite primary outcome in the group which had undergone QFR-guided PCI. Limitations of this study include only having a 1-year follow-up of clinical outcomes. Nevertheless, this study provides high-quality evidence for the implementation of QFR-guided PCI.

Click to read the study in the Lancet

Relevant Reading: Association between adherence to fractional flow reserve treatment thresholds and major adverse cardiac events in patients with coronary artery disease

RELATED REPORTS

Chronic exposure to particulate matter is associated with increased cardiovascular risk

The mortality in-hospital for patients undergoing elective catheter ablation for atrial fibrillation is low

A medical care at home program following hospitalization with acute decompensated heart failure may offer a safe and effective alternative to continued hospitalization

In-Depth [randomized controlled trial]: This multicentre randomized control trial done across 26 hospitals in China included patients ages ≥18 years, with stable or unstable angina pectoris, or myocardial infarction at least 72 hours before screening. Exclusion criteria included moderate to severe kidney disease. Before randomization, each patient had a revascularization plan made by visual angiography. Patients were randomized 1:1 to receive either QFR-guided PCI or angiography-guided PCI. The primary outcome was a composite of major adverse cardiac events, all-cause mortality, myocardial infarction, and revascularization in the following year. A total of 3825 patients participated in the study with a mean age of 62.7 years and 29.4% women. Patients were masked to their group for the duration of the 1-year follow-up.

During the procedure, QFR changed the revascularization plans of 23.3% of patients due to the added information. In 19.6% of patients, a stent was deferred in stenoses that were found to be not hemodynamically obstructive. In 4.4% of patients, QFR led to the stenting of stenoses that were found to be more hemodynamically obstructive than originally identified by angiography alone. The primary outcome occurred in 5.8% of the QFR group and 8.8% of the angiographic group. A hazard ratio of 0.65 (95% CI 0.51 to 0.83, p=0.0004) was calculated between QFR versus angiography.

Image: PD

©2021 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: acute coronary syndromeangina pectorisangiographycardiologycoronary angiographyMajor Cardiac Eventmyocardial infarctionPCIpercutaneous coronary intervention (PCI)Quantitative flow ratio (QFR)Quantitative flow ratio-guided coronary intervention
Previous Post

Nedaplatin-based concurrent chemoradiotherapy is noninferior to cisplatin-based therapy in patients with locoregional nasopharyngeal carcinoma

Next Post

Once-a-week cagrilintide is effective for weight management in overweight and obese patients

RelatedReports

Cardiology

Chronic exposure to particulate matter is associated with increased cardiovascular risk

September 10, 2026
Rivaroxaban likely reduces risk of recurrent stroke in specific subgroup of patients with embolic stroke of undetermined source
Cardiology

The mortality in-hospital for patients undergoing elective catheter ablation for atrial fibrillation is low

September 4, 2026
Remote patient monitoring did not reduce heart failure readmissions: The BEAT-HF trial
Cardiology

A medical care at home program following hospitalization with acute decompensated heart failure may offer a safe and effective alternative to continued hospitalization

July 24, 2026
Rivaroxaban likely reduces risk of recurrent stroke in specific subgroup of patients with embolic stroke of undetermined source
Cardiology

Catheter ablation within 1 year of atrial fibrillation diagnosis is associated with reduced risk of recurrence

July 24, 2026
Next Post
Many new pediatric asthma cases attributable to obesity

Once-a-week cagrilintide is effective for weight management in overweight and obese patients

#VisualAbstract: Pericardiotomy after cardiac surgery may reduce the incidence of postoperative atrial fibrillation

#VisualAbstract: Pericardiotomy after cardiac surgery may reduce the incidence of postoperative atrial fibrillation

Systematic cardiac screening may not be required amongst junior competitive athletes  

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Male sex is associated with higher mortality among patients with hepatocellular carcinoma
  • Artificial intelligence (AI)-supported symptom self-assessment led to more appropriate patient care-seeking decisions
  • Rimegepant (Nurtec ODT) may be an effective alternative to triptans for symptom relief in migraines
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.